MedTrace Logo

Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial

NCT00224315 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2008-06-04

No results posted yet for this study

Summary

We aim to compare the augmentation of clozapine with ziprasidone or risperidone in a randomized, prospective manner.

Conditions

  • Schizophrenia, Schizoaffective Disorder

Interventions

DRUG

ziprasidone

DRUG

risperidone

Sponsors & Collaborators

  • Central Institute of Mental Health, Mannheim

    lead OTHER

Principal Investigators

  • Mathias Zink, MD · Central Institute of Mental Health, Department of Psychiatry, Mannheim, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-11-30
Completion
2006-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00224315 on ClinicalTrials.gov